anonymous
Guest
anonymous
Guest
These idiots also got blindsided with the Teva Eltrombopag approval last week! Generics will now flood the market, profits will tank, and the hematology layoff will be very deep, comparable to the Synagis one. No future here.
Continuing in the Sobi tradition would not be surprised to see a number of those with upcoming LTI payments get let go before they are paid out.